Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now


Latent Tuberculosis Infection (LTBI)

9 Jun 2020

4-month rifampicin associated with decreased risk of grade 1-2 rash or grade 3-5 treatment-related adverse event leading to discontinuation compared to 9-month isoniazid in adults with LTBI (Lancet Infect Dis 2020 Mar)

13 Nov 2018

M72/AS01E vaccine reduces risk of active pulmonary TB within 2 years of vaccination in patients with LTBI (N Engl J Med 2018 Oct 25)

19 Sep 2018

review of screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis (BMJ Open 2018 Sep 12)

14 Sep 2018

4-month rifampin may be as effective as 9-month isoniazid in children with LTBI (N Engl J Med 2018 Aug 2)

27 Apr 2017

CDC/NIH/IDSA updated guideline on prevention and treatment of opportunistic infections in HIV-infected adults and adolescents (AIDSinfo 2017 Mar 28)

27 Mar 2017

ACR Appropriateness Criteria for imaging of possible tuberculosis (ACR 2016)


Subscribe for unlimited access to DynaMed content.
Already subscribed? Sign in